172 related articles for article (PubMed ID: 37392947)
1. Lopinavir and ritonavir act synergistically with azoles against Candida auris in vitro and in a mouse model of disseminated candidiasis.
Salama EA; Eldesouky HE; Elgammal Y; Abutaleb NS; Seleem MN
Int J Antimicrob Agents; 2023 Sep; 62(3):106906. PubMed ID: 37392947
[TBL] [Abstract][Full Text] [Related]
2. Potent Synergistic Interactions between Lopinavir and Azole Antifungal Drugs against Emerging Multidrug-Resistant Candida auris.
Eldesouky HE; Salama EA; Lanman NA; Hazbun TR; Seleem MN
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046487
[TBL] [Abstract][Full Text] [Related]
3. Atazanavir Resensitizes Candida auris to Azoles.
Elgammal Y; Salama EA; Seleem MN
Antimicrob Agents Chemother; 2023 May; 67(5):e0163122. PubMed ID: 37092991
[TBL] [Abstract][Full Text] [Related]
4. Saquinavir potentiates itraconazole's antifungal activity against multidrug-resistant Candida auris in vitro andin vivo.
Elgammal Y; Salama EA; Seleem MN
Med Mycol; 2023 Sep; 61(9):. PubMed ID: 37558393
[TBL] [Abstract][Full Text] [Related]
5. Azole resistance in Candida auris: mechanisms and combinatorial therapy.
Jangir P; Kalra S; Tanwar S; Bari VK
APMIS; 2023 Aug; 131(8):442-462. PubMed ID: 37337929
[TBL] [Abstract][Full Text] [Related]
6. Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris.
Eldesouky HE; Li X; Abutaleb NS; Mohammad H; Seleem MN
Int J Antimicrob Agents; 2018 Dec; 52(6):754-761. PubMed ID: 30145250
[TBL] [Abstract][Full Text] [Related]
7.
Sun Y; Tan L; Yao Z; Gao L; Yang J; Zeng T
Microbiol Spectr; 2022 Feb; 10(1):e0200721. PubMed ID: 35019705
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antifungal activity of posaconazole against Candida auris by HIV protease inhibitors, atazanavir and saquinavir.
Elgammal Y; Salama EA; Seleem MN
Sci Rep; 2024 Jan; 14(1):1571. PubMed ID: 38238403
[TBL] [Abstract][Full Text] [Related]
9. Aprepitant, an antiemetic agent, interferes with metal ion homeostasis of
Eldesouky HE; Lanman NA; Hazbun TR; Seleem MN
Virulence; 2020 Dec; 11(1):1466-1481. PubMed ID: 33100149
[TBL] [Abstract][Full Text] [Related]
10. Oropharyngeal candidiasis in HIV-infected patients under treatment with protease inhibitors.
Migliorati CA; Birman EG; Cury AE
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Sep; 98(3):301-10. PubMed ID: 15356467
[TBL] [Abstract][Full Text] [Related]
11. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF
J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167
[TBL] [Abstract][Full Text] [Related]
12. In vitro study on the potential fungicidal effects of atorvastatin in combination with some azole drugs against multidrug resistant Candida albicans.
Mahmoud DE; Faraag AHI; Abu El-Wafa WM
World J Microbiol Biotechnol; 2021 Oct; 37(11):191. PubMed ID: 34632522
[TBL] [Abstract][Full Text] [Related]
13. Genetic Analysis of
Kim SH; Iyer KR; Pardeshi L; Muñoz JF; Robbins N; Cuomo CA; Wong KH; Cowen LE
mBio; 2019 Jan; 10(1):. PubMed ID: 30696744
[No Abstract] [Full Text] [Related]
14. Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.
Wurster S; Bandi A; Beyda ND; Albert ND; Raman NM; Raad II; Kontoyiannis DP
J Antimicrob Chemother; 2019 Jul; 74(7):1904-1910. PubMed ID: 31225606
[TBL] [Abstract][Full Text] [Related]
15. Lopinavir/ritonavir: a review of its use in the management of HIV infection.
Cvetkovic RS; Goa KL
Drugs; 2003; 63(8):769-802. PubMed ID: 12662125
[TBL] [Abstract][Full Text] [Related]
16. Small molecules restore azole activity against drug-tolerant and drug-resistant
Alabi PE; Gautier C; Murphy TP; Gu X; Lepas M; Aimanianda V; Sello JK; Ene IV
mBio; 2023 Aug; 14(4):e0047923. PubMed ID: 37326546
[TBL] [Abstract][Full Text] [Related]
17. Multicenter Candida auris outbreak caused by azole-susceptible clade IV in Pernambuco, Brazil.
Spruijtenburg B; Nobrega de Almeida Júnior J; Ribeiro FC; Kemmerich KK; Baeta K; Meijer EFJ; de Groot T; Meis JF; Colombo AL;
Mycoses; 2024 Jun; 67(6):e13752. PubMed ID: 38880933
[TBL] [Abstract][Full Text] [Related]
18. Candida auris: A pathogen difficult to identify, treat, and eradicate and its characteristics in Japanese strains.
Iguchi S; Itakura Y; Yoshida A; Kamada K; Mizushima R; Arai Y; Uzawa Y; Kikuchi K
J Infect Chemother; 2019 Oct; 25(10):743-749. PubMed ID: 31257156
[TBL] [Abstract][Full Text] [Related]
19. Deciphering the Mrr1/Mdr1 Pathway in Azole Resistance of Candida auris.
Li J; Coste AT; Bachmann D; Sanglard D; Lamoth F
Antimicrob Agents Chemother; 2022 Apr; 66(4):e0006722. PubMed ID: 35343781
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
